N@N

HDSN, AIS, DV, DEPO, YDNT, PANL Are Seasonally Ripe To Go Up In the Next Five Weeks

December 20, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of HUDSON TECHNOLOGIES INC (NASDAQ:HDSN), Antares Pharma Inc (AMEX:AIS), DEVRY INC (NYSE:DV), DEPOMED INC (NASDAQ:DEPO), Young Innovations Inc (NASDAQ:YDNT), UNIVERSAL DISPLAY CORP (NASDAQ:PANL) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     HDSN       HUDSON TECHNOLOGIES INC             22.41%              81.82% (9 of 11)        Friday, January 13th 2012
     AIS        Antares Pharma Inc                  12.75%              90.00% (9 of 10)        Tuesday, January 3rd 2012
     DV         DEVRY INC                           11.79%              95.00% (19 of 20)       Monday, January 30th 2012
     DEPO       DEPOMED INC                         19.72%              90.91% (10 of 11)       Friday, January 13th 2012
     YDNT       Young Innovations Inc               7.84%               81.82% (9 of 11)        Monday, January 9th 2012
     PANL       UNIVERSAL DISPLAY CORP              7.92%               90.91% (10 of 11)       Monday, December 26th 2011

HUDSON TECHNOLOGIES INC (NASDAQ:HDSN) - Hudson Technologies, Inc., through its subsidiary, Hudson Technologies Company, provides refrigerant services and solutions in the refrigeration industry primarily in the United States. Its products and services include refrigerant sales; refrigerant management services consisting of reclamation of refrigerants and laboratory testing; and RefrigerantSide services, including system decontamination to remove moisture, oils, and other contaminants. The RefrigerantSide services also include predictive and diagnostic services for industrial and commercial refrigeration applications, which predict potential catastrophic problems and identify inefficiencies in an operating system. The company's products and services are primarily used in commercial air conditioning, industrial processing, and refrigeration systems. It sells reclaimed and new refrigerants to customers in air conditioning and refrigeration industry. The company serves commercial, industrial, and government customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers; and customers in petrochemical, pharmaceutical, industrial power, manufacturing, commercial facility, and property management and maritime industries. Hudson Technologies has a strategic alliance with The Linde Group to market its service offering outside the United States. The company was founded in 1991 and is headquartered in Pearl River, New York.

Antares Pharma Inc (AMEX:AIS) - Antares Pharma, Inc., a pharmaceutical company, focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. It offers injection devices, which include Medi-Jector Vision for insulin; Zomajet 2 Vision, Zomajet Vision X, Twin-Jector EZ II, and Tjet for human growth hormone; Vibex pressure assisted auto injector platform that enables a controlled pressure delivery of drugs into the body utilizing a spring power source; and disposable pen injectors, which are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. The company also develops/commercializes Anturol, an oxybutynin ATD (advanced transdermal delivery)gel, which is in Phase III clinical trials for the treatment of overactive bladder; Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; LibiGel, a transdermal testosterone gel that is in Phase III clinical studies for the treatment of female sexual dysfunction; Nestorone contraceptive formulation products, which has completed Phase II clinical trials; and Ropinerole to treat a central nervous system. Antares Pharma, Inc. markets its products to pharmaceutical companies primarily in the United States and Europe. It has collaborative arrangements and license agreements primarily with Teva Pharmaceutical Industries, Ltd.; BioSante Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Population Council, Ferring Pharmaceuticals BV; Eli Lilly and Company; JCR Pharmaceuticals Co., Ltd.; and Solvay Pharmaceuticals BV, as well as a strategic alliance with Uman Pharma. The company was formerly known as Medi-Ject Corporation and changed its name to Antares Pharma, Inc. in January 2001. Antares Pharma, Inc. was founded in 1979 and is based in Ewing, New Jersey.

DEVRY INC (NYSE:DV) - DeVry Inc., through its wholly owned subsidiaries, owns and operates DeVry University, Advanced Academics, Ross University, Chamberlain College of Nursing, and Becker Professional Review. DeVry University offers associate, bachelor, and master degree programs in technology, healthcare technology, business, and management at 94 locations in the United States and Canada, as well as through online platform; and graduate degree programs in management through its Keller Graduate School of Management. Advanced Academics provides online secondary education to school districts in the United States. Ross University offers medical and veterinary medical education through Ross University School of Medicine located in the Caribbean country of Dominica and Ross University School of Veterinary Medicine located in St. Kitts. Chamberlain College of Nursing provides various nursing degree and degree completion programs at its campuses in St. Louis, Missouri; Columbus, Ohio, Phoenix, Arizona; Addison, Illinois; and Jacksonville, Florida, as well as online. Becker Professional Review prepares candidates for the Certified Public Accountant and Chartered Financial Analyst professional certification examinations, as well as the Project Management Professional certification examination; and offers professional education programs and seminars in accounting and finance. These classes are taught in approximately 300 locations, including sites in 40 foreign countries and DeVry University teaching sites. The company was founded in 1931 and is headquartered in Oakbrook Terrace, Illinois.

DEPOMED INC (NASDAQ:DEPO) - Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States. It markets GLUMETZA for the treatment of type 2 diabetes in the United States and Canada; and Proquin XR for the treatment of uncomplicated urinary tract infection in the United States. The companys product candidates include DM-1796 for the treatment of postherpetic neuralgia, which has completed a Phase III clinical trial; Serada for the treatment of menopausal hot flashes, which has completed a Phase III clinical trial; DM-3458 for gastroesophageal reflux disease; and DM-1992 to treat Parkinson's disease, which has completed a Phase I clinical trial. It sells its products to wholesalers and retail pharmacies. The company has collaboration and license agreements with Solvay Pharmaceuticals, Inc.; PharmaNova, Inc.; Santarus, Inc.; Merck & Co., Inc.; Covidien, Ltd.; TEVA Pharmaceuticals USA, Inc.; King Pharmaceuticals, Inc.; Esprit Pharma, Inc.; LG Life Sciences, Ltd.; Rottapharm/Madaus S.r.l.; PharmaNova, Inc.; and Supernus Pharmaceuticals, Inc. Depomed, Inc. was founded in 1995 and is based in Menlo Park, California.

Young Innovations Inc (NASDAQ:YDNT) - Young Innovations, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of supplies and equipment used by dentists, dental hygienists, dental assistants, and consumers. It offers preventive products, such as disposable and metal prophylaxis (prophy) angles, prophy paste, fluorides in gel formulation, dental handpieces and related components, and moisture control products. The company also provides infection control products, such as liquid surface disinfectants, evacuation system cleaners, gloves and masks, ultrasonic cleaning systems, and instrument disinfectants; micro-applicators, including disposable micro-applicators and bristle brush applicators; and home care kits comprising brushes, wax to protect the inside of the cheek from irritation due to brackets, a timer to monitor brushing time, and floss, as well as toothbrushes. In addition, it offers endodontic products consisting of Obtura family of endodontic units, which are gun-type, heat-softened gutta percha delivery systems, as well as ultrasonic scaling units and handpieces; and diagnostic products, including panoramic X-ray machine and cephalometric images, as well as dental X-ray supplies comprising film, film cassettes and intensifying screens, processing chemicals, and darkroom supplies. The company sells its products primarily through distributors, as well as sells directly to dental providers and dental hygiene schools, Veterans Administration healthcare facilities, and the U.S. military bases. It markets its products primarily in the United States, Canada, Europe, South America, Central America, and the Pacific Rim. The company was founded in 1995 and is headquartered in Earth City, Missouri.

UNIVERSAL DISPLAY CORP (NASDAQ:PANL) - Universal Display Corporation engages in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials for use in flat panel display, solid-state lighting, and other product applications. It owns exclusive license or has the sole right to sublicense approximately 1,000 patents issued and pending worldwide. The company licenses and supplies its proprietary UniversalPHOLED phosphorescent OLED technologies and materials to display manufacturers and others. It also involves in the research, development, and commercialization of other OLED device and manufacturing technologies, including TOLED, which are transparent OLEDs for the fabrication of OLEDs that have transparent cathodes; FOLED that are flexible OLEDs for the fabrication of OLEDs on flexible substrates; OVPD, an organic vapor phase deposition process; UniversalP2OLED, which are printable phosphorescent OLEDs; and OVJP that is an organic vapor jet printing technology. In addition, the company provides technical assistance and support to third parties for the commercialization of their OLED products. Universal Display Corporation has strategic relationships with Samsung Mobile Display Co., Ltd.; LG Display Co., Ltd.; AU Optronics Corporation; Sony Corporation; Chimei Innolux Corporation; Tohoku Pioneer Corporation; Moser Baer Technologies, Inc.; Konica Minolta Holdings, Inc.; Denko K.K.; LG Chem, Ltd.; Panasonic Electric Works Co., Ltd.; NEC Lighting, Ltd.; Seiko Epson Corporation; and DuPont Displays, Inc. The company was founded in 1985 and is based in Ewing, New Jersey.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641